NASDAQ · Medical - Diagnostics & Research

DRIO (DRIO) Stock

$7.47 -4.11% NASDAQ: DRIO Healthcare

Valuation

MetricValue
Price$7.47
Market Cap$54.62M
P/E Ratio-10.51
P/B Ratio0.84
P/S Ratio2.52
EPS (TTM)$-0.44
52-Week High$17.74
52-Week Low$5.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-59.87%
ROA-19.73%
ROCE-54.41%
Gross Margin56.55%
Operating Margin-2.52%
Net Margin2.96%
Debt/Equity0.51
Current Ratio3.89

Annual Financials (USD)

Metric20212022202320242025
Revenue$21.0M$28.0M$20.0M$27.0M$22.0M
Operating Profit$-76.0M$-57.0M$-56.0M$-58.0M$-37.0M
Net Profit$-77.0M$-62.0M$-59.0M$-43.0M$-42.0M
EPS$-4.63$-2.63$-1.93$-0.74$1.24
Op Margin-372.9%-205.4%-276.1%-213.6%-163.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$101.0M$119.0M$96.0M$119.0M$110.0M
Total Liabilities$15.0M$39.0M$38.0M$47.0M$42.0M
Cash$36.0M$49.0M$37.0M$28.0M$26.0M
Borrowings$0$28.0M$30.0M$30.0M$32.0M

Latest News

Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform PR Newswire · Jul 16, 2026 Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15% PR Newswire · Jul 13, 2026 DarioHealth Signs Deal With Major Health Insurer in Arizona MT Newswires · Jul 6, 2026 Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership PR Newswire · Jul 6, 2026 Sector Update: Healthcare Stocks Gain Late Afternoon MT Newswires · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-50.0M$-48.0M$-30.0M$-39.0M$-26.0M
Investing Cash Flow$-8.0M$-1.0M$-1.0M$-9.0M$-4.0M
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$7.0M$14.0M$-13.0M$-9.0M$-6.0M
Free Cash Flow$-51.0M$-48.0M$-31.0M$-39.0M$-26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-435.11
EV / EBITDA-1.97
FCF Yield-47.71%
Quick Ratio2.60
Interest Coverage-12.33
Return 1Y-52.40%
Return 3Y-91.39%
Return 5Y-97.90%

Ownership

Insiders Held21.08%
Institutions Held12.03%
Institutions Float Held15.24%
Institutional HolderSharesReport Date
Nantahala Capital Management, LLC610,6902026-03-31
Vanguard Capital Management LLC65,9102026-03-31
Geode Capital Management, LLC61,8782026-03-31
Vanguard Fiduciary Trust Co30,0702026-03-31
Lasry, Marc23,2462025-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABSI $7.13 -5.69% -11.32 $1.21B 0.00%
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
FLGT $18.53 -0.11% -8.10 $526.26M 0.00%
INNV $11.36 -2.07% 24.28 $1.54B 0.00%
MYGN $2.86 -46.74% -0.91 $270.12M 0.00%

About DRIO

DRIO is led by CEO Erez Raphael, employs 196 people, headquartered in US, publicly traded since 2016.

DRIO stock trades at $7.47 with a market capitalization of $54.62M. The stock is valued at a price-to-earnings (P/E) ratio of -10.51, price-to-book of 0.84, price-to-sales of 2.52. Over the past 52 weeks the stock has ranged between $5.55 and $17.74, and currently trades 57.9% below its 52-week high.

On profitability, DRIO generates a return on equity (ROE) of -59.87%, return on capital employed of -54.41%, an operating margin of -2.52%, a net profit margin of 2.96%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides